LifeStance Health Group, Inc. (NASDAQ:LFST) Insider Ujjwal Ramtekkar Sells 16,000 Shares

LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) insider Ujjwal Ramtekkar sold 16,000 shares of the business's stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $5.94, for a total transaction of $95,040.00. Following the completion of the transaction, the insider now owns 113,435 shares of the company's stock, valued at $673,803.90. This represents a 12.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

LifeStance Health Group Price Performance

LFST traded up $0.04 during trading on Monday, hitting $5.88. The company's stock had a trading volume of 1,692,560 shares, compared to its average volume of 1,601,939. The firm has a market capitalization of $2.29 billion, a price-to-earnings ratio of -22.62 and a beta of 1.22. LifeStance Health Group, Inc. has a twelve month low of $4.64 and a twelve month high of $8.61. The business's fifty day simple moving average is $6.24 and its 200 day simple moving average is $7.08. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Handelsbanken Fonder AB purchased a new stake in LifeStance Health Group in the 4th quarter worth $128,000. Janus Henderson Group PLC increased its stake in shares of LifeStance Health Group by 51.4% during the fourth quarter. Janus Henderson Group PLC now owns 59,500 shares of the company's stock worth $439,000 after purchasing an additional 20,200 shares in the last quarter. Blue Trust Inc. increased its stake in shares of LifeStance Health Group by 124.4% during the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company's stock worth $27,000 after purchasing an additional 2,122 shares in the last quarter. Northern Trust Corp raised its position in shares of LifeStance Health Group by 11.7% during the 4th quarter. Northern Trust Corp now owns 1,591,776 shares of the company's stock worth $11,731,000 after purchasing an additional 166,731 shares during the last quarter. Finally, Geode Capital Management LLC lifted its stake in LifeStance Health Group by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 3,465,471 shares of the company's stock valued at $25,546,000 after buying an additional 13,293 shares in the last quarter. Hedge funds and other institutional investors own 85.50% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on LFST. KeyCorp began coverage on shares of LifeStance Health Group in a research report on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 price objective on the stock. Canaccord Genuity Group assumed coverage on shares of LifeStance Health Group in a report on Thursday, April 3rd. They issued a "buy" rating and a $8.00 price target on the stock. UBS Group raised LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 price target on the stock in a research report on Tuesday, May 27th. Finally, William Blair reaffirmed an "outperform" rating on shares of LifeStance Health Group in a report on Friday, February 28th. One analyst has rated the stock with a sell rating, four have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $8.50.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.